Nova Patents
ATE82500T1

Electrolyte solutions and (in vivo) use thereof.

Abstract

Processes and compositions are provided for in vitro use in tissue culture media (preferred), perfusion media, and incubation media. Thus, balanced salt solutions are provided wherein the milliequivalent ratio of sodium cations to chloride anions is normalized and wherein optionally at least one near-equilibrium couple is incorporated (bicarbonate-/carbon dioxide, L-lactate-/pyruvate-, and d-betahydroxybutyrate-/acetoacetate-. Regulation of intracellular and extracellular pH, and normalization of intracellular redox state and phosphorylation state is achievable.

Term

Term ended

Projected expiry passed 24 June 2005, 21.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

52 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
62351084United States of AmericaA
8501202United States of AmericaW

Members52

Family members, oldest first
DocumentOfficeKind
WO8600227A1World Intellectual Property Organization (WIPO)A1
WO8600335A1World Intellectual Property Organization (WIPO)A1
AU4540285AAustraliaA
AU4634685AAustraliaA
EP0185759A1European Patent Office (EPO)A1
EP0188529A1European Patent Office (EPO)A1
JPS61502933AJapanA
JPS61502943AJapanA
EP0185759A4European Patent Office (EPO)A4
IL81030A0IsraelA0
IL81030D0IsraelD0
US4663166AUnited States of AmericaA
US4663289AUnited States of AmericaA
WO8703808A1World Intellectual Property Organization (WIPO)A1
AU6776887AAustraliaA
CN86108978AChinaA
EP0249667A1European Patent Office (EPO)A1
JPS63502274AJapanA
EP0188529A4European Patent Office (EPO)A4
CA1264442ACanadaA
AU4771690AAustraliaA
CA1280082CCanadaC
AU6855890AAustraliaA
US5100677AUnited States of AmericaA
CA1304688CCanadaC
EP0249667B1European Patent Office (EPO)B1
AT80303TAustriaT
ATE80303T1AustriaT1
DE3686718D1GermanyD1
EP0185759B1European Patent Office (EPO)B1
AT82500TAustriaT
ATE82500T1This recordAustriaT1
DE3586844D1GermanyD1
EP0188529B1European Patent Office (EPO)B1
AT84066TAustriaT
ATE84066T1AustriaT1
DE3586946D1GermanyD1
DE3686718T2GermanyT2
GR3006492T3GreeceT3
DE3586844T2GermanyT2
AU6066994AAustraliaA
ES2052495T3SpainT3
AU7746694AAustraliaA
AU2488097AAustraliaA
US6020007AUnited States of AmericaA
US2003013765A1United States of AmericaA1
EP0185759B2European Patent Office (EPO)B2
USRE38604EUnited States of AmericaE
EP0249667B2European Patent Office (EPO)B2
US2005058724A1United States of AmericaA1
ES2052495T5SpainT5
DE3686718T3GermanyT3